Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Public ClinicalTrials.gov record NCT06226805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-blinded, Placebo-controlled, Single Ascending Dose, Two-part, Randomized, Phase 2 Clinical Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BB-031 in Acute Ischemic Stroke Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset. Participants will be randomized to receive one dose of either the investigational drug or placebo and will be followed for 90 days. A total of 228 patients are planned in this study.
Study identification
- NCT ID
- NCT06226805
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 228 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2024
- Primary completion
- May 31, 2027
- Completion
- Aug 31, 2027
- Last update posted
- May 13, 2026
2024 – 2027
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 14
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| HonorHealth Bob Bove Neuroscience Institute | Scottsdale | Arizona | 85251 | Recruiting |
| Mills Peninsula Medical Center | Burlingame | California | 94010 | Withdrawn |
| MemorialCare Long Beach Medical Center | Long Beach | California | 90806 | Withdrawn |
| California Pacific Medical Center | San Francisco | California | 94109 | Withdrawn |
| Pacific Neurosciences Institute at Saint John's Physician Partners | Torrance | California | 90503 | Recruiting |
| Baptist Health Medical Center | Jacksonville | Florida | 32207 | Terminated |
| Henry Ford Hospital | Detroit | Michigan | 48202 | Recruiting |
| Washington University in St. Louis | St Louis | Missouri | 63110 | Recruiting |
| Cooper University Hospital | Camden | New Jersey | 08103 | Recruiting |
| WakeMed | Raleigh | North Carolina | 27610 | Recruiting |
| The Ohio State University | Columbus | Ohio | 43210 | Recruiting |
| ProMedica Toledo Hospital | Toledo | Ohio | 43604 | Recruiting |
| Mercy Health St. Vincent Medical Center | Toledo | Ohio | 43608 | Recruiting |
| Valley Baptist Medical Center - Harlingen | Harlingen | Texas | 78550 | Recruiting |
| Memorial Hermann Hospital | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06226805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 13, 2026 · Synced Sep 8, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06226805 live on ClinicalTrials.gov.